de Vicente Fidalgo; Javier
Patent Applications and Registrations
Patent applications and USPTO patent grants for de Vicente Fidalgo; Javier.The latest application filed is for "compounds, compositions, and methods".
Company Profile
11.19.36
- de Vicente Fidalgo; Javier - Foster City CA
- de Vicente Fidalgo; Javier - South San Francisco CA
- de Vicente Fidalgo; Javier - Glen Ridge NJ US
- - Glen Ridge NJ US
Patent Activity
| Patent | Date |
|---|---|
| Compounds, Compositions, And Methods App 20220220094 - de Vicente Fidalgo; Javier ; et al. | 2022-07-14 |
| Compounds, Compositions And Methods App 20220177438 - Craig, II; Robert A. ; et al. | 2022-06-09 |
| Compounds, Compositions And Methods App 20220177456 - Craig, II; Robert A. ; et al. | 2022-06-09 |
| Compounds, Compositions And Methods App 20220153728 - Estrada; Anthony A. ; et al. | 2022-05-19 |
| Compounds, Compositions, And Methods App 20220135546 - de Vicente Fidalgo; Javier ; et al. | 2022-05-05 |
| Compound, Compositions, And Methods App 20220119371 - Estrada; Anthony A. ; et al. | 2022-04-21 |
| Compounds, compositions and methods Grant 11,306,077 - Craig, II , et al. April 19, 2 | 2022-04-19 |
| Kinase Inhibitors and Uses Thereof App 20220041620 - de Vicente Fidalgo; Javier ; et al. | 2022-02-10 |
| Modulators of eukaryotic initiation factor 2B, compositions and methods Grant 11,236,100 - Craig, II , et al. February 1, 2 | 2022-02-01 |
| Compounds, Compositions and Methods App 20220024938 - Bonanomi; Giorgio ; et al. | 2022-01-27 |
| Compound, compositions, and methods Grant 11,214,565 - Estrada , et al. January 4, 2 | 2022-01-04 |
| Kinase inhibitors and uses thereof Grant 11,203,600 - De Vicente Fidalgo , et al. December 21, 2 | 2021-12-21 |
| Compounds, compositions and methods Grant 11,174,262 - Bonanomi , et al. November 16, 2 | 2021-11-16 |
| Compounds, Compositions and Methods App 20210332058 - Estrada; Anthony A. ; et al. | 2021-10-28 |
| Substituted Pyrimidines As Lrkk2 Inhibitors App 20210300914 - ESTRADA; Anthony A. ; et al. | 2021-09-30 |
| Compounds, Compositions And Methods App 20210292311 - Craig, II; Robert A. ; et al. | 2021-09-23 |
| Compounds, compositions, and methods Grant 11,111,235 - de Vicente Fidalgo , et al. September 7, 2 | 2021-09-07 |
| Compounds, compositions and methods Grant 11,072,618 - Estrada , et al. July 27, 2 | 2021-07-27 |
| Substituted pyrimidines as LRKK2 inhibitors Grant 11,028,080 - Estrada , et al. June 8, 2 | 2021-06-08 |
| Compounds, Compositions And Methods App 20210147435 - Craig, II; Robert A. ; et al. | 2021-05-20 |
| Modulators Of Eukaryotic Initiation Factor 2 App 20210130308 - Craig, II; Robert A. ; et al. | 2021-05-06 |
| Compounds, Compositions, And Methods App 20210002260 - de Vicente Fidalgo; Javier ; et al. | 2021-01-07 |
| Compounds, Compositions And Methods App 20200331900 - Craig, II; Robert A. ; et al. | 2020-10-22 |
| Compounds, Compositions and Methods App 20200317691 - Estrada; Anthony A. ; et al. | 2020-10-08 |
| Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) Grant 10,709,692 - Bonanomi , et al. | 2020-07-14 |
| Compounds, Compositions And Methods App 20200157081 - Estrada; Anthony A. ; et al. | 2020-05-21 |
| Compounds, compositions and methods Grant 10,604,535 - Estrada , et al. | 2020-03-31 |
| Kinase Inhibitors and Uses Thereof App 20200087319 - De Vicente Fidalgo; Javier ; et al. | 2020-03-19 |
| Compounds, compositions, and methods Grant 10,590,114 - Estrada , et al. | 2020-03-17 |
| Compounds, Compositions and Methods App 20200079784 - Bonanomi; Giorgio ; et al. | 2020-03-12 |
| Compounds, Compositions and Methods App 20190300537 - Estrada; Anthony A. ; et al. | 2019-10-03 |
| Compounds, Compositions And Methods App 20190112318 - Estrada; Anthony A. ; et al. | 2019-04-18 |
| Compounds, Compositions, And Methods App 20190084975 - Estrada; Anthony A. ; et al. | 2019-03-21 |
| Isoxazolidine Derived Inhibitors Of Receptor Interacting Protein Kinase 1 (ripk1) App 20180353480 - Bonanomi; Giorgio ; et al. | 2018-12-13 |
| Compounds, compositions and methods Grant 10,131,676 - Estrada , et al. November 20, 2 | 2018-11-20 |
| Compound, Compositions, And Methods App 20180327391 - Estrada; Anthony A. ; et al. | 2018-11-15 |
| Compounds, Compositions, And Methods App 20180208582 - Estrada; Anthony A. ; et al. | 2018-07-26 |
| Compounds, Compositions And Methods App 20180099981 - Estrada; Anthony A. ; et al. | 2018-04-12 |
| Compounds, compositions, and methods Grant 9,932,325 - Estrada , et al. April 3, 2 | 2018-04-03 |
| Compounds, Compositions, And Methods App 20180051009 - Estrada; Anthony A. ; et al. | 2018-02-22 |
| Compounds, Compositions And Methods App 20180022759 - Estrada; Anthony A. ; et al. | 2018-01-25 |
| Compounds, Compositions, And Methods App 20170362206 - Estrada; Anthony A. ; et al. | 2017-12-21 |
| Compounds, compositions and methods Grant 9,815,850 - Estrada , et al. November 14, 2 | 2017-11-14 |
| Compounds, Compositions And Methods App 20170226127 - Estrada; Anthony A. ; et al. | 2017-08-10 |
| Inhibitors of Bruton's tyrosine kinase Grant 9,469,644 - De Vicente Fidalgo , et al. October 18, 2 | 2016-10-18 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20160002243 - De Vicente Fidalgo; Javier ; et al. | 2016-01-07 |
| Inhibitors of JAK Grant 8,618,103 - de Vicente Fidalgo , et al. December 31, 2 | 2013-12-31 |
| Inhibitors of JAK Grant 08618103 - | 2013-12-31 |
| Quinoline inhibitors of hepatitis C virus polymerase Grant 8,487,103 - de Vicente Fidalgo , et al. July 16, 2 | 2013-07-16 |
| Pyrrolopyrazine Kinase Inhibitors App 20130059834 - Chen; Shaoqing ; et al. | 2013-03-07 |
| Heterocyclic Antiviral Compounds App 20110300103 - de Vicente Fidalgo; Javier ; et al. | 2011-12-08 |
| Inhibitors Of Jak App 20110059118 - de Vicente Fidalgo; Javier ; et al. | 2011-03-10 |
| Heterocyclic Antiviral Compounds App 20100311760 - de Vicente Fidalgo; Javier ; et al. | 2010-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 